Watch industry experts from around the world discuss the findings from the 2021 “Beyond Intervention” research covering challenges in the earliest stages of the vascular patient care, including health equity barriers. Nick West, M.D. Chief Medical Officer and DVP Global Medical Affairs, Abbott’s Vascular Business, is joined by Abbott colleague Jennifer Jones-McMeans, PhD, DVP of Clinical Affairs, David G. Armstrong, D.P.M., M.D., PhD, Progressor of Surgery, Director, USC, and David Rhew, M.D. Chief Medical Officer and VP of Healthcare at Microsoft.
You are about to enter an Abbott country- or region-specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
Do you wish to continue and enter this website?